Get started
Roche Holding Ltd Dividend Right Cert.Roche Holding Ltd Dividend Right Cert.Roche Holding Ltd Dividend Right Cert.

Roche Holding Ltd Dividend Right Cert.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.24 T‬ MXN
Dividend yield (indicated)
2.80%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
361.93 MXN
Net income (FY)
‪292.89 B‬ MXN
Revenue (FY)
‪1.40 T‬ MXN
Shares float
‪689.63 M‬
Beta (1Y)
1.50

About Roche Holding Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
IPO date
May 4, 2001
Identifiers
2
ISIN CH0012032048
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as ROG/N.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
5.42%
Maturity date
Dec 13, 2051
R
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.34%
Maturity date
Mar 8, 2054
R
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.33%
Maturity date
Mar 8, 2054
G
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.30%
Maturity date
Jul 15, 2035
R
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.19%
Maturity date
Nov 28, 2044
R
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.15%
Maturity date
Mar 8, 2034
R
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.07%
Maturity date
Mar 8, 2031
R
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.95%
Maturity date
Mar 8, 2029
R
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
4.95%
Maturity date
Mar 1, 2039
R
CHGCY6244754
Roche Holdings, Inc. 4.666% 02-DEC-2035
Yield to maturity
4.74%
Maturity date
Dec 2, 2035
R
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
4.64%
Maturity date
Mar 8, 2034

See all ROG/N bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight
0.73%
Market value
‪4.24 B‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
1.00%
Market value
‪2.74 B‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
1.28%
Market value
‪2.19 B‬
USD
CHDVD
iShares Swiss Dividend ETF (CH)
Weight
15.85%
Market value
‪1.32 B‬
USD
EFA
iShares MSCI EAFE ETF
Weight
1.49%
Market value
‪1.10 B‬
USD
CHSPI
iShares Core SPI(R) ETF (CH)
Weight
13.90%
Market value
‪932.64 M‬
USD
EFV
iShares MSCI EAFE Value ETF
Weight
2.85%
Market value
‪835.57 M‬
USD
SMICHA
UBS ETF (CH) - SMI ETF -CHF dis-
Weight
18.47%
Market value
‪788.05 M‬
USD
SMIA
UBS ETF (CH) - SMI ETF Units -CHF acc-
Weight
18.47%
Market value
‪788.05 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
1.92%
Market value
‪716.55 M‬
USD
SCHF
Schwab International Equity ETF
Weight
1.14%
Market value
‪673.75 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of ROG/N is 7,794.59 MXN — it has increased by 29.51% in the past 24 hours. Watch Roche Holding Ltd Dividend Right Cert. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange Roche Holding Ltd Dividend Right Cert. stocks are traded under the ticker ROG/N.
ROG/N stock has risen by 27.38% compared to the previous week, the month change is a 27.38% rise, over the last year Roche Holding Ltd Dividend Right Cert. has showed a 36.75% increase.
We've gathered analysts' opinions on Roche Holding Ltd Dividend Right Cert. future price: according to them, ROG/N price has a max estimate of 9,625.34 MXN and a min estimate of 5,184.61 MXN. Watch ROG/N chart and read a more detailed Roche Holding Ltd Dividend Right Cert. stock forecast: see what analysts think of Roche Holding Ltd Dividend Right Cert. and suggest that you do with its stocks.
ROG/N stock is 23.48% volatile and has beta coefficient of 1.50. Track Roche Holding Ltd Dividend Right Cert. stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd Dividend Right Cert. there?
Today Roche Holding Ltd Dividend Right Cert. has the market capitalization of ‪6.30 T‬, it has increased by 4.06% over the last week.
Yes, you can track Roche Holding Ltd Dividend Right Cert. financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd Dividend Right Cert. is going to release the next earnings report on Jul 23, 2026. Keep track of upcoming events with our Earnings Calendar.
ROG/N earnings for the last half-year are 190.56 MXN per share, whereas the estimation was 195.20 MXN, resulting in a −2.38% surprise. The estimated earnings for the next half-year are 246.61 MXN per share. See more details about Roche Holding Ltd Dividend Right Cert. earnings.
Roche Holding Ltd Dividend Right Cert. revenue for the last half-year amounts to ‪703.99 B‬ MXN, despite the estimated figure of ‪707.01 B‬ MXN. In the next half-year revenue is expected to reach ‪695.30 B‬ MXN.
ROG/N net income for the last half-year is ‪124.39 B‬ MXN, while the previous report showed ‪175.19 B‬ MXN of net income which accounts for −29.00% change. Track more Roche Holding Ltd Dividend Right Cert. financial stats to get the full picture.
Yes, ROG/N dividends are paid annually. The last dividend per share was 223.06 MXN. As of today, Dividend Yield (TTM)% is 2.77%. Tracking Roche Holding Ltd Dividend Right Cert. dividends might help you take more informed decisions.
Roche Holding Ltd Dividend Right Cert. dividend yield was 2.99% in 2025, and payout ratio reached 61.57%. The year before the numbers were 3.80% and 93.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, ROG/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd Dividend Right Cert. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Roche Holding Ltd Dividend Right Cert. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Roche Holding Ltd Dividend Right Cert. stock shows the strong buy signal. See more of Roche Holding Ltd Dividend Right Cert. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.